Thurston Springer Miller Herd & Titak’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Buy
8,301
+2,266
+38% +$528K 0.77% 24
2026
Q1
$1.48M Sell
6,035
-1,458
-19% -$340K 0.61% 30
2025
Q4
$1.55M Buy
7,493
+6,239
+498% +$1.23M 0.54% 34
2025
Q3
$232K Sell
1,254
-26,755
-96% -$4.58M 0.46% 59
2025
Q2
$4.28M Buy
28,009
+5,277
+23% +$811K 0.55% 37
2025
Q1
$3.77M Buy
22,732
+4,844
+27% +$758K 0.63% 33
2024
Q4
$2.59M Buy
17,888
+4,661
+35% +$722K 0.52% 43
2024
Q3
$2.14M Buy
13,227
+822
+7% +$131K 0.59% 30
2024
Q2
$1.81M Buy
+12,405
New +$1.84M 0.56% 30

Other funds holding JNJ

Thurston Springer Miller Herd & Titak's JNJ Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Johnson & Johnson (JNJ) stake by 38% in Q2 2026, buying an estimated $528K and bringing the position to 8,301 shares worth $2.11M. The position accounts for 0.77% of the portfolio, ranked #24.

Thurston Springer Miller Herd & Titak first reported a position in JNJ in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.28M in Q2 2025. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 8,301 shares of Johnson & Johnson worth $2.11M as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 2,266 Johnson & Johnson shares in Q2 2026, an estimated $528K.
  • Johnson & Johnson made up 0.77% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #24 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Johnson & Johnson in Q2 2024 and has held it in 9 quarters since.
  • Thurston Springer Miller Herd & Titak's Johnson & Johnson position peaked at $4.28M in Q2 2025.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.